, !50% stenosis (OR 19.5 95%CI 2.77 to 137.4; p< 0.01), and multiple SBI (OR 3.85 95%CI 1.23 to 12.0; p<0.05). Conclusion The evaluation of intracranial artery stenosis and SBI may be useful to identify ischemic stroke patients at high risk for subclinical CAD.
Introduction

Cerebrovascular disease and coronary artery disease (CAD) have similar risk factors and often coexist. Previous studies have shown that 25% of stroke patients have a history of symptomatic coronary events (1) and 25-60% of these patients show subclinical CAD on provocative testing
with asymptomatic myocardial ischemia (9) .
Intracranial artery stenosis (10) , silent brain infarction (SBI) (11, 12) , and white matter lesions (11, 12) evaluated as brain ischemia on magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) are associated with future stroke and mortality both in the general population and in ischemic stroke patients. Some studies have examined these lesions in patients with CAD (13) (14) (15) (16) ; however the relationship between these lesions and the presence of subclinical CAD in ischemic stroke patients remains unclear.
We have recently reported the prevalence of subclinical cardiovascular diseases in ischemic stroke patients using coronary computed tomographic angiography (CTA) and various surrogate markers of systemic atherosclerosis, and examined the association between the presence of subclinical CAD and vascular risk factors (17) . Here, we investigated the usefulness of elements of brain ischemia to predict the presence of subclinical CAD in ischemic stroke patients. Table 3 .
Methods
Study population
We investigated 243 consecutive patients who were admitted to our hospital for their first-ever ischemic stroke from May 2005 to March 2007. Diagnosis of ischemic stroke was based on sudden onset of loss of cerebral function persisting for >24 hours as well as findings from MRI. Patients
T a b l e 1 . B a s e l i n e Ch a r a c t e r i s t i c s
The severity of intracranial artery stenosis and the number of SBI
The relationship between the severity of intracranial artery stenosis and subclinical CAD is shown in Fig. 2 Table 4 in details PVH, periventricular hyperintensity; DSWMH, deep and subcortical white matter hyperintensity Fig. 2 
i n g t o t h e c o mb i n a t i o n o f i n t r a c r a n i a l a r t e r y s t e n o s i s a n d S B I . T h e χ 2 t e s t f o r 4 g r o u p s r e v e a l e d s i g n i f i c a n t d i f f e r e n c e s , s h o wi n g t h a t p a t i e n t s wi t h b o t h i n t r a c r a n i a l a r t e r y s t e n o s i s a n d S B I h a d t h e h i g h e s t p r e s e n c e o f s u b c l i n i c a l CAD ( p < 0 . 0 0 1 ) .
T a b l e 2 . MRI a n d MRA F i n d i n g s
T a b l e 3 . Mu l t i v a r i a t e An a l y s e s f o r t h e P r e v a l e n c e o f S u b c l i n i c a l CAD
OR 19.5 95%CI 2.77 to 137.4; p<0.01) both resulted in a significantly increased risk of the presence of subclinical CAD. The relationship between the number of SBI and subclinical CAD is also shown in
F i g u r e 2 . T h e p r e s e n c e o f s u b c l i n i c a l CAD a c c o r d i n g t o t h e s e v e r i t y o f i n t r a c r a n i a l a r t e r y s t e n o s i s a n d t h e n u mb e r o f S B I . T h e χ
t e s t f o r a l l 3 c a t e g o r i e s r e v e a l e d s i g n i f i c a n t d i f f e r e n c e s , s h o wi n g t h a t p a t i e n t s wh o h a v e a d v a n c e d i n t r a c r a n i a l a r t e r y s t e n o s i s h a d a h i g h e r p r e s e n c e o f s u b c l i n i c a l CAD ( p < 0 . 0 0 1 ) , a n d p a t i e n t s wh o h a v e ma n y S B I h a d a l s o h i g h e r p r e s e n c e o f s u b c l i n i c a l CAD ( p < 0 . 0 5 ) .
T a b l e 4 . Re l a t i o n s h i p b e t we e n t h e S e v e r i t y o f I n t r a c r a n i a l Ar t e r y S t e n o s i s , t h e Nu mb e r o f S i l e n t B r a i n I n f a r c t i o n s , a n d t h e P r e v a l e n c e o f S u b c l i n i c a l CAD
Discussion
This study showed that 36% of ischemic stroke patients had subclinical CAD in accord with previous studies using provocative testing for myocardial ischemia (2) (3) (4) (5) . Intracranial artery stenosis determined by MRA and SBI determined by MRI were well associated with the presence of subclinical CAD in ischemic stroke patients.
Intracranial artery stenosis and CAD have the same pathogenesis and share many risk factors. Autopsy studies (21, 22) and small clinical studies (3, 4, 13-15 ) have confirmed the coexistence of these two diseases. Some studies have confirmed that coronary atherosclerosis was accompanied by latent atherosclerotic lesions in the intracranial arteries not in ischemic stroke patients, but in patients with CAD (13, 14) . Other studies examined patients with intracranial artery stenosis not using arterial wall imaging, but using provocative testing for myocardial ischemia (3, 4) . Recently, an autopsy study confirmed a relationship between the severity of intracranial atherosclerosis, coronary plaques, and coronary stenosis in patients with fatal stroke (22) . The authors suggested that future studies examine nonfatal strokes using arterial wall imaging, which is the approach reported in this paper. Their study showed that the prevalence of CAD ! 50% stenosis) in patients without plaque, with plaque, and with >30% stenosis of intracranial arteries was about 20%, 40%, and 40%, respectively. The present study found that the prevalence of subclinical CAD in patients without stenosis, with <50% stenosis, and with !50% stenosis was 16%, 47%, and 73%, respectively (Fig.1) . The relationship of between intracranial and coronary atherosclerosis is therefore nearly identical between fatal and nonfatal stroke patients.
SBI is primarily caused by lacunar infarction, but also partially caused by embolic infarction (23) (24) (25) . Most silent infarcts are found to be small deep lesions (26) . Depending on the lesion site, small deep infarcts may be less likely to be noticed by the patient than infarcts involving the cortex (24) . Embolic infarctions are associated with cortical infarcts that are mostly symptomatic (27) . The small-vessel vasculopathy causing lacunar infarctions may be the result of smallvessel hyalinosis rather than small-vessel atherothrombosis (28) . Old age and hypertension have been identified previously as the most important risk factors for SBI (23) . However, some studies have confirmed that CAD risk factors such as dyslipidemia, diabetes mellitus, smoking, hyperhomocysteinemia (29) , metabolic syndrome (30) , and expression of inflammatory markers (31) were also associated with SBI, and that SBI was more advanced in patients with CAD, indicating that small artery disease may play a parallel role to systemic atherosclerosis of large arteries such as the coronary arteries in SBI progression (15) . Previous studies demonstrated that SBI in ischemic stroke patients was associated with the risk of future stroke (11, 12) , dementia (32) , and mortality (11, 12) , but failed to investigate future cardiovascular disease (12) (33) . This damage can be caused by arteriosclerosis (34) , amyloid angiopathy (35) , and sclerosing vasculopathy (36) , and can also reflect various pathologic conditions such as perivascular demyelination, dilated perivascular spaces, myelin pallor, and gliosis (37) . White matter lesions have been attributed not only to aging and hypertension (27) but also to other vascular risk factors (38) . Similarly to SBI, white matter lesions have been associated with future strokes (11, 12) , dementia (38) , and mortality (12) (1) , subclinical CAD (2) (3) (4) (5) , and subsequent coronary events (7, 8) 
Conclusion
The present study determined that 36% of patients with first-ever ischemic stroke had subclinical CAD by means of arterial wall imaging. The evaluation of intracranial artery stenosis and SBI were useful to identify ischemic stroke patients at high risk for subclinical CAD. These variables may provide risk stratification for screening of subclinical CAD.
